Insider Trading & Ownership - SAENGER BRADLEY

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SAENGER BRADLEY

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-27
Option Award
2024-02-29
5:07 pm
2025-02-27
2034-02-27
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
564,000$0564,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:37 pm
2024-02-23
2033-02-23
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
400,000$0400,000
(Direct)
View
2022-02-15
Option Award
2022-02-17
5:19 pm
2023-02-15
2032-02-15
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
3,600,000$03,600,000
(Direct)
View
2021-06-30
Ownership
2022-02-11
5:18 pm
N/A
N/A
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
18,248$0.5819,645
(Direct)
View
2021-02-23
Option Award
2021-02-25
5:52 pm
2022-02-23
2031-02-23
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
1,080,000$01,080,000
(Direct)
View
2020-01-06
Ownership
2021-02-12
5:32 pm
N/A
N/A
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
493$1.021,397
(Direct)
View
2020-05-04
Option Award
2020-05-06
6:26 pm
2021-05-04
2030-05-04
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
720,000$0720,000
(Direct)
View
2020-02-25
Option Award
2020-02-27
4:24 pm
2021-02-25
2030-02-25
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
48,000$048,000
(Direct)
View
2019-02-17
Ownership
2020-02-14
4:14 pm
N/A
N/A
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
59$17.85904
(Direct)
View
2019-07-31
Ownership
2020-02-14
4:14 pm
N/A
N/A
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
815$11.82904
(Direct)
View
2019-05-06
Option Award
2019-05-08
08:00 am
2020-05-06
2029-05-06
Tonix Pharmaceuticals Holding Corp.TNXPSAENGER BRADLEY
Chief Financial Officer
57,670$057,670
(Direct)
View